King Pharmaceuticals Recalls Embeda
On March 10, 2011, King Pharmaceuticals, Inc., a subsidiary of Pfizer, Inc., voluntarily recalled all dosage forms of Embeda® (morphine and naltrexone) extended release capsules from U.S. wholesalers and retailers. According to King, a pre-specified stability requirement was not met during routine testing.Based on available data, King... Read more




